evenfolioETF Details
Invesco·Health·PBE · NYSE Arca
Invesco Biotechnology & Genome ETF (PBE)
- Price
- $102.50
- —30 Oct 2026
- Assets
- $423.5M
- Total net assets
- Expense ratio
- 0.59%
- Category 1.00%
- Yield
- 1.37%
- Trailing distributions
- 1Y return
- 42.3%+13.5%
- Category 28.8%
- 3Y CAGR
- 25.6%+4.0%
- Category 21.5%
- 5Y CAGR
- 6.9%+2.8%
- Category 4.1%
Loading NAV history…
Invesco Biotechnology & Genome ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +5.4% | +14.4% | +29.9% | +26.1% | +42.3% | +25.6% | +6.9% | +10.9% | +9.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +1.8% | +4.5% | +6.9% | +5.7% | +13.5% | +4.0% | +2.8% | +0.1% | -1.9% |
Holdings
The 10 largest positions make up 48.2% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| NTRA | Natera Inc | 6.23% |
| ILMN | Illumina Inc | 6.17% |
| BIIB | Biogen Inc | 5.19% |
| GILD | Gilead Sciences Inc | 5.08% |
| AMGN | Amgen Inc | 4.84% |
| VRTX | Vertex Pharmaceuticals Inc | 4.80% |
| RPRX | Royalty Pharma PLC Class A | 4.77% |
| REGN | Regeneron Pharmaceuticals Inc | 4.62% |
| MRNA | Moderna Inc | 3.36% |
| NVAX | Novavax Inc | 3.17% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 26.6
- P/B
- 4.4
- P/S
- 4.7
- P/CF
- 15.2
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- Invesco
- Category
- Equity · Health
- Ticker
- PBE
- Exchange
- NYSE Arca
- Inception
- 23 Jun 2005 (21.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.59% (category 1.00%)
- Holdings turnover
- 103% (category 51%)
- Distribution yield
- 1.37%
- Beta, 3 years
- 0.73
- Total net assets
- $423.5M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PTH · Invesco Dorsey Wright Healthcare Momentum ETFInvesco · $367M · ER 0.60%5Y 2.5%
- PINK · Simplify Health Care ETFSimplify Asset Management · $349M · ER 0.51%5Y 9.7%
- IDNA · iShares Genomics Immunology and Healthcare ETFiShares · $299M · ER 0.47%5Y -2.0%
- XHS · State Street SPDR S&P Health Care Services ETFState Street Investment Management · $218.5M · ER 0.35%5Y 6.4%
- SBIO · ALPS Medical Breakthroughs ETFALPS · $211.6M · ER 0.50%5Y 4.3%
- CANC · Tema Oncology ETFTema ETFs · $208.6M · ER 0.75%